CLINICAL_TRIALS
trial_result
· 2015-06-18
Clinical Trial Update: Incretin Effect and Use After Clinical Islet Transplantation [Phase 2]
Summary
Phase 2 trial results examining the incretin effect and its use after clinical islet transplantation in individuals with Type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2015-06-18